BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND KDR, VEGFR2, 3791, ENSG00000128052, P35968, VEGFR, CD309, FLK1 AND Diagnosis
38 results:

  • 1. Anlotinib alone or in combination with bevacizumab in the treatment of recurrent high-grade glioma: a prospective single-arm, open-label phase II trial.
    Zhao S; Zhang M; Zhang Q; Wu J; Dai H
    BMC Cancer; 2024 Jan; 24(1):6. PubMed ID: 38166698
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II LOLA trial.
    Corti F; Brizzi MP; Amoroso V; Giuffrida D; Panzuto F; Campana D; Prinzi N; Milione M; Cascella T; Spreafico C; Randon G; Oldani S; Leporati R; Scotto G; Pulice I; Stocchetti BL; Porcu L; Coppa J; Di Bartolomeo M; de Braud F; Pusceddu S
    BMC Cancer; 2023 Sep; 23(1):908. PubMed ID: 37752423
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Repeatedly next-generation sequencing during treatment follow-up of patients with small cell lung cancer.
    JiaXin Y; XiaoFeng C; PengFei C; Songchen Z; Ziling L
    Medicine (Baltimore); 2023 Jun; 102(26):e34143. PubMed ID: 37390276
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Peripancreatic paraganglioma: Lesson from a round table.
    Petrelli F; Fratini G; Sbrozzi-Vanni A; Giusti A; Manta R; Vignali C; Nesi G; Amorosi A; Cavazzana A; Arganini M; Ambrosio MR
    World J Gastroenterol; 2022 Jun; 28(21):2396-2402. PubMed ID: 35800185
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The Overexpression of SLC25A13 Predicts Poor Prognosis and Is Correlated with Immune cell Infiltration in Patients with Skin Cutaneous Melanoma.
    Lv Y; Yuan CH; Han LY; Huang GR; Ju LC; Chen LH; Han HY; Zhang C; Zeng LH
    Dis Markers; 2022; 2022():4091978. PubMed ID: 35607442
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Parity is associated with better prognosis in ovarian germ cell tumors, but not in other ovarian cancer subtypes.
    Sköld C; Koliadi A; Enblad G; Stålberg K; Glimelius I
    Int J Cancer; 2022 Mar; 150(5):773-781. PubMed ID: 34648676
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The kdr (vegfr-2) Genetic Polymorphism Q472H and c-KIT Polymorphism M541L Are Associated With More Aggressive Behaviour in Astrocytic Gliomas.
    Zaman N; Dass SS; DU Parcq P; Macmahon S; Gallagher L; Thompson L; Khorashad JS; LimbÄck-Stanic C
    Cancer Genomics Proteomics; 2020; 17(6):715-727. PubMed ID: 33099473
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A SEMA3 Signaling Pathway-Based Multi-Biomarker for Prediction of Glioma Patient Survival.
    Valiulyte I; Steponaitis G; Kardonaite D; Tamasauskas A; Kazlauskas A
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036421
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Targeted Therapy with Anlotinib for a Patient with an Oncogenic FGFR3-TACC3 Fusion and Recurrent Glioblastoma.
    Wang Y; Liang D; Chen J; Chen H; Fan R; Gao Y; Gao Y; Tao R; Zhang H
    Oncologist; 2021 Mar; 26(3):173-177. PubMed ID: 32949176
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Phase II study of Dovitinib in recurrent glioblastoma.
    Sharma M; Schilero C; Peereboom DM; Hobbs BP; Elson P; Stevens GHJ; McCrae K; Nixon AB; Ahluwalia MS
    J Neurooncol; 2019 Sep; 144(2):359-368. PubMed ID: 31292802
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors.
    Schäfer N; Gielen GH; Rauschenbach L; Kebir S; Till A; Reinartz R; Simon M; Niehusmann P; Kleinschnitz C; Herrlinger U; Pietsch T; Scheffler B; Glas M
    J Transl Med; 2019 Mar; 17(1):96. PubMed ID: 30894200
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinical and Molecular Characterization of Adult Glioblastomas in Southern Brazil.
    Trevisan P; Graziadio C; Rodrigues DBK; Rosa RFM; Soares FP; Provenzi VO; de Oliveira CAV; Paskulin GA; Varella-Garcia M; Zen PRG
    J Neuropathol Exp Neurol; 2019 Apr; 78(4):297-304. PubMed ID: 30840759
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Correlation of Vascular Endothelial Growth Factor subtypes and their receptors with melanoma progression: A next-generation Tissue Microarray (ngTMA) automated analysis.
    Seyed Jafari SM; Wiedmer C; Cazzaniga S; Frangež Ž; Shafighi M; Beltraminelli H; Weber B; Simon HU; Hunger RE
    PLoS One; 2018; 13(11):e0207019. PubMed ID: 30408085
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Spontaneous intracerebral hemorrhage as presentation of atypical central neurocytoma: the role of angiogenesis through the characterization of tumor endothelial cells.
    Marfia G; Pirola E; Navone SE; Beretta M; Guarnaccia L; Trombetta E; Franzini A; Rampini P; Campanella R
    Histol Histopathol; 2018 Jul; 33(7):665-672. PubMed ID: 29215136
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Molecular alterations in pediatric brainstem gliomas.
    Porkholm M; Raunio A; Vainionpää R; Salonen T; Hernesniemi J; Valanne L; Satopää J; Karppinen A; Oinas M; Tynninen O; Pentikäinen V; Kivivuori SM
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28792659
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Silencing of cZNF292 circular RNA suppresses human glioma tube formation via the Wnt/β-catenin signaling pathway.
    Yang P; Qiu Z; Jiang Y; Dong L; Yang W; Gu C; Li G; Zhu Y
    Oncotarget; 2016 Sep; 7(39):63449-63455. PubMed ID: 27613831
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Copy Number Profiling of Brazilian Astrocytomas.
    Bidinotto LT; Torrieri R; Mackay A; Almeida GC; Viana-Pereira M; Cruvinel-Carloni A; Spina ML; Campanella NC; Pereira de Menezes W; Clara CA; Becker AP; Jones C; Reis RM
    G3 (Bethesda); 2016 Jul; 6(7):1867-78. PubMed ID: 27172220
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.
    Ascierto PA; Atkins M; Bifulco C; Botti G; Cochran A; Davies M; Demaria S; Dummer R; Ferrone S; Formenti S; Gajewski TF; Garbe C; Khleif S; Kiessling R; Lo R; Lorigan P; Arthur GM; Masucci G; Melero I; Mihm M; Palmieri G; Parmiani G; Puzanov I; Romero P; Schilling B; Seliger B; Stroncek D; Taube J; Tomei S; Zarour HM; Testori A; Wang E; Galon J; Ciliberto G; Mozzillo N; Marincola FM; Thurin M
    J Transl Med; 2015 Nov; 13():374. PubMed ID: 26619946
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Neuropilin-1 (NRP-1) and Magnetic Nanoparticles, a Potential Combination for diagnosis and Therapy of Gliomas.
    Chen L; Zhang G; Shi Y; Qiu R; Khan AA
    Curr Pharm Des; 2015; 21(37):5434-49. PubMed ID: 26377659
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway.
    Tabouret E; Tchoghandjian A; Denicolai E; Delfino C; Metellus P; Graillon T; Boucard C; Nanni I; Padovani L; Ouafik L; Figarella-Branger D; Chinot O
    Oncotarget; 2015 May; 6(13):11664-75. PubMed ID: 25860928
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.